Ovulation disorders: the WHO groups and their causes
On this page you will learn
- The three WHO groups of ovulation disorder
- How hormone tests sort a woman into a group
- Where raised prolactin and thyroid disease fit
- The treatment aim for each group, in principle
- Why tablets do not suit every group
Principles only. Medicines and doses are decided by the treating specialist for each patient; this page explains principles only.
Three groups, three different problems
The World Health Organization (WHO) grouping sorts anovulation by where the fault lies. The fault lies in the brain signals, in their balance, or in the ovary itself. Each group needs a different treatment, so name the group before you plan.
Source: 2025, Wolters Kluwer / Taylor, Pal, Seli (eds) - Speroff's Clinical Gynecologic Endocrinology and Infertility, 10th edition
| Group | Hormone picture | Common causes | Treatment aim |
|---|---|---|---|
| I: hypothalamus or pituitary | Low FSH and LH, low oestrogen | Low weight, heavy exercise, stress, pituitary disease | Restore the signal |
| II: normal signals, out of balance | FSH normal, oestrogen present | Mostly PCOS | One follicle, one egg |
| III: ovary | High FSH, low oestrogen | Premature ovarian insufficiency | Counsel; tablets do not work |
Source: 2025, Wolters Kluwer / Taylor, Pal, Seli (eds) - Speroff's Clinical Gynecologic Endocrinology and Infertility, 10th edition
Group I: the signal is missing
The hypothalamus or pituitary makes too little gonadotropin, so follicles never start. Look for low weight, eating disorders, hard training and pituitary disease. Correct weight and energy balance first.
When treatment is needed, the ovary must receive the signal directly. That means gonadotropins with LH activity, or pulsed gonadotropin-releasing hormone (GnRH). Tablets do not help, because they work through oestrogen feedback that is absent here.
Source: 31 Mar 2026, NICE - Fertility problems: assessment and treatment (NG257), recommendation 1.30.2
Group II: the largest group
Signals are present but out of balance, and a dominant follicle fails to emerge. Polycystic ovary syndrome (PCOS) explains most of these women (page 18). Oral ovulation induction is the usual first step (page 19).
Source: 2023, International PCOS Network / Monash University (Teede et al.) - International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023
Group III: the ovary has run short
Follicles are few or absent, so follicle-stimulating hormone (FSH) is high while oestrogen is low. Stimulation, by tablet or injection, rarely helps. Counsel with care, check general health, including bone health, and discuss all options openly. Donor eggs are covered on page 68.
Source: 2025, Wolters Kluwer / Taylor, Pal, Seli (eds) - Speroff's Clinical Gynecologic Endocrinology and Infertility, 10th edition
Prolactin and thyroid
Raised prolactin switches off the ovulation signal. Test prolactin only in a woman with an ovulation disorder, breast discharge or a pituitary tumour, not routinely. Treat raised prolactin with a dopamine agonist such as cabergoline.
Source: 31 Mar 2026, NICE - Fertility problems: assessment and treatment (NG257), recommendations 1.18.11 and 1.32.1
Test thyroid function in a woman with symptoms of thyroid disease. Correct any disorder before ovulation induction.
Source: 31 Mar 2026, NICE - Fertility problems: assessment and treatment (NG257), recommendation 1.18.12
At the clinic
Observed only. You classify five anonymised cases into a WHO group, using history and hormone results. Then you state the treatment aim for each case and check it with the clinical faculty.
Common mistakes
- Giving tablets to a thin athlete with low FSH and low oestrogen
- Stimulating a woman with a high FSH and very few antral follicles
- Testing prolactin in every woman instead of those with a reason
- Starting ovulation induction before correcting thyroid disease
Key points
- Name the WHO group before you plan treatment.
- Group I needs the signal restored; tablets do not work.
- Group II is mostly PCOS; oral ovulation induction comes first.
- Group III rarely responds to stimulation; counsel honestly.
Check yourself
1. A woman has low FSH, low LH and low oestrogen. Which group?
WHO group I.
2. Why do tablets fail in group I?
They work through oestrogen feedback, which is absent.
3. Which condition explains most of group II?
Polycystic ovary syndrome (PCOS).
4. Who should have a prolactin test?
Women with an ovulation disorder, breast discharge or a pituitary tumour.
5. From page 16: how do you confirm ovulation in a woman with regular cycles?
Mid-luteal progesterone, about 7 days before the next period.
Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.
Questions on this page
What are the WHO groups of ovulation disorder?
Group I: low brain signals (hypothalamus or pituitary). Group II: normal signals out of balance, mostly PCOS. Group III: the ovary itself has run short of follicles.
Does every woman who does not ovulate need tablets?
No. Tablets suit group II. Group I needs the brain signal replaced, and group III rarely responds to stimulation.
The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.
